
Coral Laboratories (CORALAB) Share Price near 52-Week High after 7.87% Rise
Updated: 19 Nov 2026 • 10:24 am
Posted by:

Coral Laboratories Share Price is Rs 670, up 7.87%, and trading near its 52-week high with market capitalisation of Rs 221.89 crore. According to latest Univest data, Coral Laboratories Ltd. (CORALAB) is in focus after moving close to its yearly high.
Coral Laboratories Share Price opened the day on a firm note and is trading at Rs 670, up Rs 48.90 or 7.87% from the previous close of Rs 621.10. The current move places Coral Laboratories Share Price close to its 52-week high, with the day’s high at Rs 674.40 and market capitalisation at Rs 221.89 crore. The latest Univest data confirms a near 52-week high event, but it does not establish a company-specific catalyst. For readers tracking Coral Laboratories Share Price Today, the move is relevant because it combines a sharp intraday gain with a price level that is close to the stock’s yearly high. Coral Laboratories Stock News is therefore centred on the price event, the valuation picture and the broader healthcare industry context, rather than on any unverified trigger.
Coral Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 670 |
| Previous Close | Rs 621.1 |
| Today's Move | +Rs 48.9 (+7.87%) |
| Open | Rs 640 |
| High | Rs 674.4 |
| Low | Rs 623 |
| Market Capitalisation | Rs 221.89 crore |
Coral Laboratories Ltd. (CORALAB) traded at Rs 670 versus the previous close of Rs 621.1, a rise of 7.87%. The stock opened at Rs 640, reached a high of Rs 674.4 and touched a low of Rs 623.
Coral Laboratories Share Price Today shows a clear upward move within the current range. The stock opened at Rs 640 and moved between Rs 623 and Rs 674.40, with Rs 670 still well above the previous close of Rs 621.10. That means Coral Laboratories Share Price added Rs 48.90 during the session and was trading very close to the day’s high as of 19 November 2026 at 10:22 AM IST. The stock is also near its 52-week high, which keeps Coral Laboratories Share Price in the market’s focus as a one-year high name. This is the key take-away from Coral Laboratories Stock News today: the price is near the yearly high, but the verified data alone only shows the move, not the reason behind it. Coral Laboratories Share Price Update remains an event-led story rather than a catalyst-led one.
For investors following Coral Laboratories Share Price Live and Coral Laboratories Share News, the important reading is straightforward. The gap between the current price and the previous close is material, and the stock is now in a zone where the 52-week high matters as a reference point. Coral Laboratories Share Price News also deserves attention because the current level is not just above the prior close; it is positioned close to the top end of the day’s range. That makes Coral Laboratories NSE and Coral Laboratories BSE tracking important for market observers who monitor stocks in news and 52 Week High Stocks.
Coral Laboratories Ltd. (CORALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 221.89 crore |
| P/E Ratio | 10.14x |
| P/B Ratio | 0.98x |
| ROE | 7.98% |
| ROCE | 11.14% |
| EPS | Rs 61.23 |
| Book Value Per Share | Rs 633.28 |
| Dividend Yield | 0.32% |
Coral Laboratories Ltd. (CORALAB) fundamental metrics show P/E 10.14x, P/B 0.98x, ROE 7.98%, ROCE 11.14%. These figures provide context only and are not a buy or sell signal.
Coral Laboratories Ltd. has a market capitalisation of Rs 221.89 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 10.14x, P/B at 0.98x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.98% and ROCE of 11.14%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 61.23, book value per share of Rs 633.28, dividend yield of 0.32%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.6x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 10.14x |
| Benchmark Median P/E | 26.6x |
| Benchmark Average P/E | 51.17x |
| Benchmark P/E Range | 0x to 1,378.1x |
| Company P/B Ratio | 0.98x |
| Benchmark Median P/B | 2.79x |
| Company ROE | 7.98% |
| Benchmark Median ROE | 11.22% |
| Company ROCE | 11.14% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 221.89 crore |
| Benchmark Median Market Cap | Rs 789.58 crore |
Coral Laboratories Ltd. (CORALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Coral Laboratories Ltd. (CORALAB) has a P/E ratio of 10.14x, which is below the benchmark median of 26.6x, a difference of -61.88%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Coral Laboratories Ltd. (CORALAB) has a ROE of 7.98%, which is below the benchmark median of 11.22%, a difference of -28.88%. Coral Laboratories Ltd. (CORALAB) has a ROCE of 11.14%, which is below the benchmark median of 13.1%, a difference of -14.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Gennex Laboratories Ltd. | GENNE | 221.08 | 11.7 | 0.94 | 10.4 | 10.7 |
| Accretion Pharmaceuticals Ltd. | ACCPL | 224.04 | 23.17 | 4.3 | 28.72 | 29.77 |
| Everest Organics Ltd. | EVERESTO | 224.46 | 45.81 | 2.79 | 7.68 | 11.98 |
| BDH Industries Ltd. | BDH | 226.2 | 19.89 | 2.91 | 15.11 | 20.88 |
| Zenotech Laboratories Ltd. | ZENOTECH | 238.63 | 0 | 2.6 | -1.12 | 4.38 |
Coral Laboratories Ltd. (CORALAB) has a P/E ratio of 10.14x compared with the displayed peer median of 19.89x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.98% compares with a peer median of 10.4% across the companies shown in the table. ROCE stood at 11.14% versus the displayed peer median of 11.98%, providing a capital-efficiency comparison. Coral Laboratories Ltd. (CORALAB) has a market capitalisation of Rs 221.89 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Coral Laboratories
- Coral Laboratories Share Price is trading at Rs 670, up 7.87% from the previous close of Rs 621.10.
- Coral Laboratories Share Price is close to its 52-week high, with the day’s high at Rs 674.40.
- Coral Laboratories Share Price has a PE ratio of 10.14 and a PB ratio of 0.98.
- Coral Laboratories Share Price shows ROE of 7.98% and ROCE of 11.14%.
- Coral Laboratories Share Price sits near peer-market-cap levels within the Pharmaceuticals & Drugs industry.
About Coral Laboratories
Coral Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Coral Laboratories Share Price is therefore followed as part of a listed pharmaceutical set that is tracked by investors looking at Coral Laboratories NSE and Coral Laboratories BSE updates. The company’s recent quarterly revenue was Rs 36.37 crore for Sep 2026, and its market capitalisation is Rs 221.89 crore. Coral Laboratories Share Price Today is being watched alongside the company’s valuation and return ratios, which provide a compact but factual company overview for readers following Coral Laboratories Latest News and Coral Laboratories Company News.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Coral Laboratories Share Price in focus today?
Ans. Coral Laboratories Share Price is in focus because it is trading at Rs 670, up 7.87% from the previous close, and is close to its 52-week high. The move is factual and confirmed by latest Univest data.
What is Coral Laboratories Share Price today?
Ans. Coral Laboratories Share Price today is Rs 670. The stock opened at Rs 640, touched Rs 674.40, and remained above the previous close of Rs 621.10 during the current market update.
How close is Coral Laboratories Share Price to its 52-week high?
Ans. Coral Laboratories Share Price is close to its 52-week high, with the day’s high at Rs 674.40. That makes the stock a near 52-week high name in the current session.
What does Coral Laboratories Share Price indicate on valuation?
Ans. Coral Laboratories Share Price is trading at a PE ratio of 10.14 and a PB ratio of 0.98. Both are below the same-industry medians of 26.6 and 2.79, respectively.
How do Coral Laboratories earnings and book value compare?
Ans. Coral Laboratories Share Price is backed by EPS of Rs 61.23 and book value of Rs 633.28 per share. Those figures help place the stock’s current price within a measurable fundamental context.
What are the profitability ratios for Coral Laboratories?
Ans. Coral Laboratories Share Price comes with ROE of 7.98% and ROCE of 11.14%. Both figures are below the same-industry medians, which keeps the valuation discussion grounded in relative comparison.
How does Coral Laboratories compare with peers?
Ans. Coral Laboratories Share Price at a PE of 10.14 is lower than several peers such as Accretion Pharmaceuticals and BDH Industries. Its market capitalisation of Rs 221.89 crore is also near the peer cluster.
Where can I track Coral Laboratories Share Price on Univest?
Ans. You can track Coral Laboratories Share Price on Univest for live price updates, valuation ratios, EPS, book value, dividend yield and 52-week levels. It also helps readers follow Coral Laboratories Stock News and Market Cap data.
Track Coral Laboratories Share Price on Univest
Use Coral Laboratories Ltd. (CORALAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Coral Laboratories Share Price on Univest for live price updates, market capitalisation, PE ratio, PB ratio, ROE, ROCE, EPS, book value, dividend yield and 52-week levels. Univest also helps readers follow Coral Laboratories Stock News, Coral Laboratories Share Price Live and Coral Laboratories Stock Analysis in one place.
Coral Laboratories Share Price remains a near 52-week high story, with a fresh move that stands out in the current market update. For readers searching Coral Laboratories Share Price Today, Coral Laboratories Stock News Today or Coral Laboratories Share Price News, the core facts are the price, the valuation backdrop and the industry comparison. Coral Laboratories Share Price is now one of the names to monitor in Healthcare and Pharmaceuticals & Drugs alongside other 52 Week High Stocks and market movers in the Indian Stock Market.
Recent Articles

Omara Ventures India Ltd. (OMARA) Ventures India 52 Week High Streak: Second Straight Session Near Peak
19 November 2026

Shellz India Ltd. (SHELLZ) 52 Week High Streak: Back-to-Back Gains Continue
19 November 2026

HIGHWAY INFRASTRUCTURE L (HILINFRA) Share Price Near 52-Week High as HILINFRA Trades at Rs 81.36
19 November 2026

KMC Speciality Hospitals (India) Ltd. (KMCSHIL): KMC Speciality Hospitals 52 Week High Streak: Near Yearly High For Second Straight Session
19 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Omara Ventures India Ltd. (OMARA) Ventures India 52 Week High Streak: Second Straight Session Near Peak
Shellz India Ltd. (SHELLZ) 52 Week High Streak: Back-to-Back Gains Continue
HIGHWAY INFRASTRUCTURE L (HILINFRA) Share Price Near 52-Week High as HILINFRA Trades at Rs 81.36
KMC Speciality Hospitals (India) Ltd. (KMCSHIL): KMC Speciality Hospitals 52 Week High Streak: Near Yearly High For Second Straight Session
Source Industries (India) Ltd. (SOURCEIND) 52 Week High Streak: Second Straight Session Near One-Year Peak
Popular this week
Core4 Engineers Limited (CORE4) Engineers Share Price near 52-week low as stock trades at Rs 74.77

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





